Tumor necrosis factor‐α inhibitor‐induced follicular psoriasiform eruption

Tumor necrosis factor‐α inhibitor‐associated adverse cutaneous reactions are common in patients with inflammatory bowel disease. Infection‐related dermatoses and psoriasiform eruptions are seen most frequently. We describe a follicular psoriasiform eruption that appeared during treatment with inflix...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberger, Tal, Benshushan, Stephanie, Davidovics, Zev, Wilschanski, Michael, Molho‐Pessach, Vered
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541162/
https://www.ncbi.nlm.nih.gov/pubmed/35466459
http://dx.doi.org/10.1111/pde.14993
_version_ 1784803864157880320
author Goldberger, Tal
Benshushan, Stephanie
Davidovics, Zev
Wilschanski, Michael
Molho‐Pessach, Vered
author_facet Goldberger, Tal
Benshushan, Stephanie
Davidovics, Zev
Wilschanski, Michael
Molho‐Pessach, Vered
author_sort Goldberger, Tal
collection PubMed
description Tumor necrosis factor‐α inhibitor‐associated adverse cutaneous reactions are common in patients with inflammatory bowel disease. Infection‐related dermatoses and psoriasiform eruptions are seen most frequently. We describe a follicular psoriasiform eruption that appeared during treatment with infliximab in two adolescents with Crohn's disease.
format Online
Article
Text
id pubmed-9541162
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95411622022-10-14 Tumor necrosis factor‐α inhibitor‐induced follicular psoriasiform eruption Goldberger, Tal Benshushan, Stephanie Davidovics, Zev Wilschanski, Michael Molho‐Pessach, Vered Pediatr Dermatol Case Reports Tumor necrosis factor‐α inhibitor‐associated adverse cutaneous reactions are common in patients with inflammatory bowel disease. Infection‐related dermatoses and psoriasiform eruptions are seen most frequently. We describe a follicular psoriasiform eruption that appeared during treatment with infliximab in two adolescents with Crohn's disease. John Wiley and Sons Inc. 2022-04-24 2022 /pmc/articles/PMC9541162/ /pubmed/35466459 http://dx.doi.org/10.1111/pde.14993 Text en © 2022 The Authors. Pediatric Dermatology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Goldberger, Tal
Benshushan, Stephanie
Davidovics, Zev
Wilschanski, Michael
Molho‐Pessach, Vered
Tumor necrosis factor‐α inhibitor‐induced follicular psoriasiform eruption
title Tumor necrosis factor‐α inhibitor‐induced follicular psoriasiform eruption
title_full Tumor necrosis factor‐α inhibitor‐induced follicular psoriasiform eruption
title_fullStr Tumor necrosis factor‐α inhibitor‐induced follicular psoriasiform eruption
title_full_unstemmed Tumor necrosis factor‐α inhibitor‐induced follicular psoriasiform eruption
title_short Tumor necrosis factor‐α inhibitor‐induced follicular psoriasiform eruption
title_sort tumor necrosis factor‐α inhibitor‐induced follicular psoriasiform eruption
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541162/
https://www.ncbi.nlm.nih.gov/pubmed/35466459
http://dx.doi.org/10.1111/pde.14993
work_keys_str_mv AT goldbergertal tumornecrosisfactorainhibitorinducedfollicularpsoriasiformeruption
AT benshushanstephanie tumornecrosisfactorainhibitorinducedfollicularpsoriasiformeruption
AT davidovicszev tumornecrosisfactorainhibitorinducedfollicularpsoriasiformeruption
AT wilschanskimichael tumornecrosisfactorainhibitorinducedfollicularpsoriasiformeruption
AT molhopessachvered tumornecrosisfactorainhibitorinducedfollicularpsoriasiformeruption

Ejemplares similares